J Korean Rheum Assoc.  2003 Jun;10(2):101-110.

Treatment of Behcet's Disease

Affiliations
  • 1Department of Internal Medicine, College of Medicine, Dankook University, Cheonan, Korea.

Abstract

Behcet's disease is a chronic inflammatory disease with various organ involvements, its pathogenesis being unclear. It runs the clinical course of unpredictable exacerbations and remissions. In addition to a triple syndrome of oral ulceration, genital ulceration, and uveitis, there may be the involvement of other systems, such as joints, gastrointestinal tract, central nervous system, vessels, heart, or lungs. Although we have more information about the agents, through the controlled studies, that have been already available to us, the considerable portions of managements have been still done empirically. In addition, the major goal of treatment is to suppress an inflammatory status of the disease and therapy should be tailored according to the disease activity and involved organ. In these days, promising data have also been accumulated in the tumor necrosis factor inhibitors, especially in Behcet's patients with severe manifestations refractory to conventional treatments.

Keyword

Behcet's disease; Treatment

MeSH Terms

Central Nervous System
Gastrointestinal Tract
Heart
Humans
Joints
Lung
Oral Ulcer
Tumor Necrosis Factor-alpha
Ulcer
Uveitis
Tumor Necrosis Factor-alpha
Full Text Links
  • JKRA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr